New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 26, 2013
07:48 EDTAVNRAvanir Pharmaceuticals receives CHMP opinion for approval of Nuedexta in Europe
Avanir Pharmaceuticals announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for Nuedexta, recommending Nuedexta be approved for the treatment of pseudobulbar affect, irrespective of neurologic cause. In addition, the CHMP also recommended approval of two dose strengths of Nuedexta; 20/10 mg and 30/10 mg capsules.
News For AVNR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:10 EDTAVNRAvanir downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
December 12, 2014
11:01 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
December 10, 2014
15:25 EDTAVNRNotable companies reporting after market close
Subscribe for More Information
December 8, 2014
10:20 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
05:50 EDTAVNRStocks with implied volatility movement; AVNR MNKD
Subscribe for More Information
December 5, 2014
10:40 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use